Transfusion-Related Acute Lung Injury (TRALI) Caused by Antibodies to HLA-DRB1* 07:01 and HLA-DQB1*02:02: A Case Report

Overview

Journal Clin Case Rep

Date 2023 Dec 18

PMID 38107079

Authors

Menggentuya Huang

Xingtong Wang

Li Wang

Guanyi Chen

Affiliations

Soon will be listed here.

Abstract

Transfusion-related acute lung injury (TRALI) is characterized by non-cardiogenic pulmonary edema and acute hypoxemia. There are few reports of HLA-II antibodies causing TRALI in China.

Citing Articles

Huang M, Wang X, Wang L, Chen G Clin Case Rep. 2023; 11(12):e8284.

PMID: 38107079 PMC: 10724081. DOI: 10.1002/ccr3.8284.

References

Sivakaanthan A, Swain F, Pahn G, Goodison K, Gutta N, Holdsworth R . Transfusion-related acute lung injury (TRALI): a retrospective review of reported cases in Queensland, Australia over 20 years. Blood Transfus. 2022; 20(6):454-464. PMC: 9726622. DOI: 10.2450/2022.0020-22. View

Chapman C, Williamson L . National Blood Service TRALI Reduction Policies: Implementation and Effect. Transfus Med Hemother. 2011; 35(2):93-96. PMC: 3076341. DOI: 10.1159/000119116. View

Wakamoto S, Fujihara M, Sakagawa H, Takahashi D, Niwa K, Morioka M . Endothelial permeability is increased by the supernatant of peripheral blood mononuclear cells stimulated with HLA Class II antibody. Transfusion. 2008; 48(10):2060-8. DOI: 10.1111/j.1537-2995.2008.01809.x. View

Reil A, Keller-Stanislawski B, Gunay S, Bux J . Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors. Vox Sang. 2009; 95(4):313-7. DOI: 10.1111/j.1423-0410.2008.01092.x. View

Weber L, Roberts L, Sweeney J . Residual plasma in red blood cells and transfusion-related acute lung injury. Transfusion. 2014; 54(10):2425-30. DOI: 10.1111/trf.12662. View

Nishimura M, Hashimoto S, Takanashi M, Okazaki H, Satake M, Nakajima K . Role of anti-human leucocyte antigen class II alloantibody and monocytes in development of transfusion-related acute lung injury. Transfus Med. 2007; 17(2):129-34. DOI: 10.1111/j.1365-3148.2006.00721.x. View

Eder A, Herron Jr R, Strupp A, Dy B, White J, Notari E . Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006-2008). Transfusion. 2010; 50(8):1732-42. DOI: 10.1111/j.1537-2995.2010.02652.x. View

Hao X, Wang J, Li T, Wang Q . Transfusion-Related Acute Lung Injury Caused by HLA-II Antibodies: A Case Report. Lab Med. 2022; 54(5):e117-e120. DOI: 10.1093/labmed/lmac145. View

Xia W, Ye X, Xu X, Chen D, Deng J, Chen Y . The prevalence of leucocyte alloantibodies in blood donors from South China. Transfus Med. 2016; 25(6):385-92. DOI: 10.1111/tme.12276. View

10.

Kopko P, Paglieroni T, Popovsky M, Muto K, MacKenzie M, Holland P . TRALI: correlation of antigen-antibody and monocyte activation in donor-recipient pairs. Transfusion. 2003; 43(2):177-84. DOI: 10.1046/j.1537-2995.2003.00307.x. View

11.

Chapman C, Stainsby D, Jones H, Love E, Massey E, Win N . Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion. 2008; 49(3):440-52. DOI: 10.1111/j.1537-2995.2008.01948.x. View

12.

Shao L, Zhang S, Yu W, Zhou S, Duan Y, Pan L . HLA-A, HLA-B, HLA-DRB1 allele and haplotype frequencies of 14,529 Chinese Han bone marrow donors living in Dalian, China. Int J Immunogenet. 2016; 43(2):79-85. DOI: 10.1111/iji.12248. View

13.

Tung J, Chiaretti S, Dean M, Sultana A, Reade M, Fung Y . Transfusion-related acute lung injury (TRALI): Potential pathways of development, strategies for prevention and treatment, and future research directions. Blood Rev. 2022; 53:100926. DOI: 10.1016/j.blre.2021.100926. View

14.

Huang M, Wang X, Wang L, Chen G . Transfusion-Related acute lung injury (TRALI) caused by antibodies to HLA-DRB1* 07:01 and HLA-DQB1*02:02: A case report. Clin Case Rep. 2023; 11(12):e8284. PMC: 10724081. DOI: 10.1002/ccr3.8284. View

15.

Vlaar A, Binnekade J, Prins D, Van Stein D, Hofstra J, Schultz M . Risk factors and outcome of transfusion-related acute lung injury in the critically ill: a nested case-control study. Crit Care Med. 2009; 38(3):771-8. DOI: 10.1097/CCM.0b013e3181cc4d4b. View

16.

Guo K, Ma S . The Immune System in Transfusion-Related Acute Lung Injury Prevention and Therapy: Update and Perspective. Front Mol Biosci. 2021; 8:639976. PMC: 8024523. DOI: 10.3389/fmolb.2021.639976. View

17.

Zhou X, Zhu F, Li J, Mao W, Zhang D, Liu M . High-Resolution Analyses of Human Leukocyte Antigens Allele and Haplotype Frequencies Based on 169,995 Volunteers from the China Bone Marrow Donor Registry Program. PLoS One. 2015; 10(9):e0139485. PMC: 4589403. DOI: 10.1371/journal.pone.0139485. View

18.

Kopko P, Bux J, Toy P . Antibodies associated with TRALI: differences in clinical relevance. Transfusion. 2018; 59(3):1147-1151. DOI: 10.1111/trf.15094. View

19.

Vossoughi S, Gorlin J, Kessler D, Hillyer C, Van Buren N, Jimenez A . Ten years of TRALI mitigation: measuring our progress. Transfusion. 2019; 59(8):2567-2574. DOI: 10.1111/trf.15387. View

20.

Wakamoto S, Fujihara M, Takahashi D, Niwa K, Sato S, Kato T . Enhancement of endothelial permeability by coculture with peripheral blood mononuclear cells in the presence of HLA Class II antibody that was associated with transfusion-related acute lung injury. Transfusion. 2010; 51(5):993-1001. DOI: 10.1111/j.1537-2995.2010.02910.x. View